Medicines Australia has released its proposed solutions to increase the number of new medicines available in Australia on the ...

German family-owned pharma major Boehringer Ingelheim and UK-based Lifebit today announced a new three year agreement to ...

Swedish biotech SynAct Pharma today announced results from a post-hoc analysis of the Phase IIb ADVANCE study evaluating ...

The methicillin-resistant Staphylococcus aureus (MRSA) therapeutics market across the seven major pharmaceutical markets (7MM ...

Danish pharma major Novo Nordisk today announced first results from the STEP Young Phase III trial, evaluating once-weekly ...

US biotech Stoke Therapeutics (Nasdaq: STOK) and USA-based biotech major Biogen (Nasdaq: BIIB) have set out long-term results ...

Australian late-stage biotech Neurizon Therapeutics today announced the appointment of Dr Chris Bremer as chief executive (CEO), effective October1, 2026.

Symbiosis Services, a UK-based specialist aseptic fill-finish contract development and manufacturing organisation (CDMO) headquartered in Stirling, Scotland, has appointed Jos Vergeest as senior ...

CNS specialist NeuShen Therapeutics, a biotech with research and development centers in Shanghai, China and Boston, Massachusetts, has closed an oversubscribed Series B financing round exceeding $80 ...

Japanese pharma major Shionogi today announced that it has received marketing authorization from the Therapeutic Goods Administration (TGA) in Australia for cefiderocol, a siderophore cephalosporin ...

Medicines regulators in major international markets have issued a mix of first-in-class approvals, safety reviews, supply and shortage measures, consultations and one authorization suspension over the ...

Pharma trade group Innovative Medicines Canada (IMC) welcomes Deloitte Canada’s report showing the innovative pharmaceutical industry is a strategically important sector for Canada’s economic growth ...